Immune system 'double agent' could be new ally in cancer fight
St. Jude Children's Research Hospital scientists have discovered that an enzyme called TAK1 functions like a "double agent" in the innate immune response, serving as an unexpected regulator of inflammation and cell death. ...
Mar 16, 2018
0
171